The team from Seed People Consulting, a local Newcastle-based HR Consultancy, are sponsoring this year’s Cystic Fibrosis (CF) Race Day at Newcastle Racecourse on Saturday 10 June 2023.
Having raised over $20,000 with past events, this is the fifth time Seed are participating in a CF event.
In previous years they have committed to the CF walk, both physically and virtually (in pandemic years), bringing in friends and family of the Seed team to join them in raising funds for this worthwhile cause.
This year Seed are key sponsors in the Cystic Fibrosis Race Day at Newcastle Racecourse in June.
The day is set to bring together family, friends and supporters in an exciting and fun-filled day, raising much-needed funds for John Hunter Children’s Hospital and John Hunter Hospital Cystic Fibrosis Clinics who support the families in the Hunter living with Cystic Fibrosis.
Founder and Principal Consultant, Stacey Kelly said that supporting Cystic Fibrosis Community Care has always been close to her heart.
“My niece was diagnosed with CF when she was just 6 weeks old,” Stacey said.
“Because of events like this, we can ensure that CF Community Care can continue to support families in the Hunter who need to provide 24/7 care for their loved ones who have CF.
“We’ve seen firsthand the impact that this positive support can have and feel privileged to be able to directly sponsor a local event like this.”
Cystic Fibrosis is an inherited, genetic condition that alters the way salt is transferred in and out of cells. Too much salt in the cells causes mucus to be very thick and sticky and to build up in the organs.
It mainly affects the lungs, digestive system and the sweat glands. Sadly, it is the most common life‑shortening, recessive genetic condition in Australia.
From birth, a person with CF undergoes constant medical treatments and physiotherapy.
In Australia, one in 2,500 babies are born with CF, that’s one every four days and on average one in 25 people carry the CF gene and most are unaware that they are carriers.
Because carriers of CF are unaffected and therefore show no symptoms, it is hard for them to understand that CF may be a real risk.
“Being part of this event is important to me,” Stacey continued.
“Especially since we can share it with our close-knit team at Seed. Our dream is to continue supporting CF fundraising and educational events, to enable researchers to one day find a cure for CF.”
